Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Circulating Plasma Cells Are the Most Powerful Prognostic Marker in Transplant Ineligible Multiple Myeloma with 2% As a New Cut-Off for Primary Plasma Cell Leukemia

Tomas Jelinek, Renata Bezděková, David Zihala, Tereza Sevcikova, Lenka Capkova, Petra Polackova, Martin Stork, Zdenka Knechtova, Ondrej Venglar, Artur Jurczyszyn, Jorge J. Castillo, Miroslav Penka, Jakub Radocha, Sabina Sevcikova, Ludek Pour, Lucie Rihova, Roman Hajek

Blood (2021) 138 (Supplement 1): 546.

https://doi.org/10.1182/blood-2021-151592

Published: 2021

Journal Articles

Deregulated Expression of Long Non-Coding RNAs UCA1, NEAT1 and BDNF-As in Multiple Myeloma

Lenka Sedlarikova, MSc, Barbora Gromesova, MSc, Jana Filipova, MSc, Veronika Kubaczkova, MSc, Lenka Radova, PhD, Martina Almasi, PhD, Miroslav Penka, MD PhD, Zdenek Adam, MD PhD, Ludek Pour, MD PhD, Marta Krejci, MD PhD, Sabina Sevcikova, RNDr, PhD, Roman Hajek, prof, MD PhD

Blood (2016) 128 (22): 2073.

https://doi.org/10.1182/blood.V128.22.2073.2073

Published: 2016

Journal Articles

Identification of Phenotype Profile Related to the Extramedullary Involvement in Multiple Myeloma Relapse

Lucie Rihova, PhD, Pavla Vsianska, MSc, Renata Bezdekova, MSc, Zdenek Adam, prof, MD PhD, Miroslav Penka, prof, MD PhD, Tomas Jelinek, MD, Sabina Sevcikova, RNDr, PhD, Ludek Pour, MD PhD, Roman Hájek, prof, MD PhD

Blood (2016) 128 (22): 5653.

https://doi.org/10.1182/blood.V128.22.5653.5653

Published: 2016

Journal Articles

Genome Wide Profiling Of Chromosomal Abnormalities In 37 Patients With Monoclonal Gammopathy Of Undetermined Significance (MGUS)

Aneta Mikulasova, Vladimira Vallova, Jan Smetana, Henrieta Greslikova, Renata Kupska, Michaela Purgertova, Lucie Rihova, Viera Sandecka, Ludek Pour, Miroslav Penka, Petr Kuglik, Roman Hajek

Blood (2013) 122 (21): 1874.

https://doi.org/10.1182/blood.V122.21.1874.1874

Published: 2013

Journal Articles

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

Heinz Gisslinger, Mirjana Gotic, Jerzy Holowiecki, Miroslav Penka, Juergen Thiele, Hans-Michael Kvasnicka, Robert Kralovics, Petro E. Petrides

Blood (2013) 121 (10): 1720–1728.

https://doi.org/10.1182/blood-2012-07-443770

Published: 2013

Includes: Supplemental data

Journal Articles

Distinct Genetic Lesions Drive Leukemogenesis in Secondary Acute Myeloid Leukemia,

Blood (2011) 118 (21): 3559.

https://doi.org/10.1182/blood.V118.21.3559.3559

Published: 2011

Journal Articles

Thrombosis in MPN with Thrombocythemia Is Associated with Higher Platelet Count At the Time of the Event: Data From the Czech Registry of Patients Treated with Anagrelide,

Jiri Schwarz, MD, PhD, Miroslav Penka, MD, PhD, Petra Ovesna, PhD, Olga Cerna, MD, Yvona Brychtova, MD, Petr Dulicek, MD, PhD

Blood (2011) 118 (21): 3857.

https://doi.org/10.1182/blood.V118.21.3857.3857

Published: 2011

Journal Articles

The Nestin Expression in Monoclonal Gammopathies

Lucie Kovarova, PhD, Hana Svachova, Karthick Raja Muthu Raja, M.Sc, Tamara Varmuzova, Pavla Zarbochova, Miroslav Penka, MD, PhD, Roman Hajek, MD, PhD

Blood (2011) 118 (21): 5111.

https://doi.org/10.1182/blood.V118.21.5111.5111

Published: 2011

Journal Articles

Characterization of Chromosome 20q Deletions In Myeloproliferative Neoplasms Using Microarray Karyotyping and Next-Generation Sequencing

Roland Jäger, Tiina Berg, Ashot Harutyunyan, Thorsten Klampfl, Francesco Passamonti, Elisa Rumi, Daniela Pietra, Bettina Gisslinger, Damla Olcaydu, Miroslav Penka, Heinz Gisslinger, Mario Cazzola, Robert Kralovics

Blood (2010) 116 (21): 4099.

https://doi.org/10.1182/blood.V116.21.4099.4099

Published: 2010

Journal Articles

Phenotypic Analysis of CD19+ Subsets In Monoclonal Gammopathy Patients

Lucie Kovarova, PhD, Pavla Zarbochova, PhD, Tamara Varmuzova, PhD, Ivana Buresova, Karthick Raja Muthu Raja, M.Sc, Miroslav Penka, prof., MD, PhD, Roman Hajek, prof., MD, PhD

Blood (2010) 116 (21): 4998.

https://doi.org/10.1182/blood.V116.21.4998.4998

Published: 2010

Journal Articles

Long-Term Experience with Anagrelide (Thromboreductin®) In the Treatment of Essential Thrombocythemia: Data from an International Registry

Michael Steurer, Heinz Gisslinger, Miroslav Penka, Siegfried Sormann, Jiri Schwarz, Elena Tothova, Mikulas Hrubisko, Andrzej Hellmann, Maria Podolak-Dawidziak, Petro E. Petrides

Blood (2010) 116 (21): 5064.

https://doi.org/10.1182/blood.V116.21.5064.5064

Published: 2010

Journal Articles

Association Study of Ploidy Category with Mitotic Disruption In Multiple Myeloma

Elena Dementyeva, MD, Fedor Kryukov, MD, Sabina Sevcikova, PhD, Pavel Nemec, Smetana Jan, Henrieta Greslikova, Romana Zaoralova, Ivana Buresova, Miroslav Penka, MD, PhD, Petr Kuglik, PhD, Roman Hajek, MD, PhD

Blood (2010) 116 (21): 2952.

https://doi.org/10.1182/blood.V116.21.2952.2952

Published: 2010

Journal Articles

Prognostic Significance of Morphological Evaluation of Tumor Cells in Multiple Myeloma.

Mohammed Al-sahmani, MD, Irena Trnavska, Monika Antosova, Libuse Antosova, Jarmila Kissova, MD, Hana Filkova, M.Sc., Jan Smetana, M.Sc., Zdenek Adam, MD, Prof., Ludek Pour, MD, Marta Krejci, MD, Lenka Zahradova, MD, Alena Bulikova, MD, Miroslav Penka, Prof., Petr Kuglik, Ass., Prof., Roman Hajek, MD, Prof.

Blood (2009) 114 (22): 4889.

https://doi.org/10.1182/blood.V114.22.4889.4889

Published: 2009

Journal Articles

Assessment of Immature Platelet Fraction in Patients with Ph-Negative Myeloproliferative Disorders and Thrombocytosis.

Ondrej Zapletal, Jan Blatny, Michaela Selingerova, Jiri Jarkovsky, Miroslav Penka

Blood (2009) 114 (22): 4980.

https://doi.org/10.1182/blood.V114.22.4980.4980

Published: 2009

Journal Articles

Final Results of the ANAHYDRET-Study: Non-Inferiority of Anagrelide Compared to Hydroxyurea in Newly Diagnosed WHO-Essential Thrombocythemia Patients

Heinz Gisslinger, Mirjana Gotic, Jerzy Holowiecki, Miroslav Penka, Juergen Thiele, Hans Michael Kvasnicka, Robert Kralovics, Petro E. Petrides

Blood (2008) 112 (11): 661.

https://doi.org/10.1182/blood.V112.11.661.661

Published: 2008

Journal Articles

JAK2 Mutation and Additional Thrombophilic Markers Predispose to Thrombosis in Myeloproliferative Diseases with Thrombocythemia

Miroslav Penka, Jiri Schwarz, Michael Doubek, MD, PhD, Petr Dulicek, Karel Indrak, Yvona Brychtova, MD, Antonin Hlusí, Jarmila Kissova, Jiri Mayer, MD, Tomas Pavlik

Blood (2008) 112 (11): 5257.

https://doi.org/10.1182/blood.V112.11.5257.5257

Published: 2008

Journal Articles

Low Molecular Weight Heparin in Sufficient Dose of ≥70 IU/kg as an Effective and Safe Thromboprophylaxis in Patients with Newly Diagnosed Multiple Myeloma during Conventional VAD Induction Therapy.

Blood (2007) 110 (11): 2732.

https://doi.org/10.1182/blood.V110.11.2732.2732

Published: 2007

Journal Articles

Non-Inferiority of Anagrelide Compared to Hydroxyurea in Newly Diagnosed Patients with Essential Thrombocythemia: The ANAHYDRET-Study.

Heinz Gisslinger, MD, Robert Kralovics, PhD, Mirjana Gotic, MD, Jercy Holowiecki, MD, PhD, Miroslav Penka, MD, Rudolf Widmann, MD, Petro Petrides, MD

Blood (2007) 110 (11): 3547.

https://doi.org/10.1182/blood.V110.11.3547.3547

Published: 2007

Journal Articles

Expression of MAGE-A1 and MAGE-A3 in Bone Marrow from Monoclonal Gammapathy to Myeloma Patients.

Jana Necasova, MSc, Jitka Kadlecova, MSc., PhD., Renata Spesna, Miroslav Penka, M.D., Roman Hajek, M.D.

Blood (2007) 110 (11): 4752.

https://doi.org/10.1182/blood.V110.11.4752.4752

Published: 2007

Journal Articles

Phenotypic Analysis of Plasma Cells in Monoclonal Gammopathy and Multiple Myeloma Subjects.

Lucie Kovarova, Ivana Buresova, Ludek Pour, M.D., Renata Suska, Zdenek Adam, M.D., Marta Krejci, M.D., PhD., Jiri Vorlicek, M.D., Miroslav Penka, M.D., Roman Hajek, M.D.

Blood (2007) 110 (11): 4755.

https://doi.org/10.1182/blood.V110.11.4755.4755

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Circulating Plasma Cells Are the Most Powerful Prognostic Marker in Transplant Ineligible Multiple Myeloma with 2% As a New Cut-Off for Primary Plasma Cell Leukemia

Deregulated Expression of Long Non-Coding RNAs UCA1, NEAT1 and BDNF-As in Multiple Myeloma

Identification of Phenotype Profile Related to the Extramedullary Involvement in Multiple Myeloma Relapse

Genome Wide Profiling Of Chromosomal Abnormalities In 37 Patients With Monoclonal Gammopathy Of Undetermined Significance (MGUS)

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

Distinct Genetic Lesions Drive Leukemogenesis in Secondary Acute Myeloid Leukemia,

Thrombosis in MPN with Thrombocythemia Is Associated with Higher Platelet Count At the Time of the Event: Data From the Czech Registry of Patients Treated with Anagrelide,

The Nestin Expression in Monoclonal Gammopathies

Characterization of Chromosome 20q Deletions In Myeloproliferative Neoplasms Using Microarray Karyotyping and Next-Generation Sequencing

Phenotypic Analysis of CD19+ Subsets In Monoclonal Gammopathy Patients

Long-Term Experience with Anagrelide (Thromboreductin®) In the Treatment of Essential Thrombocythemia: Data from an International Registry

Association Study of Ploidy Category with Mitotic Disruption In Multiple Myeloma

Prognostic Significance of Morphological Evaluation of Tumor Cells in Multiple Myeloma.

Assessment of Immature Platelet Fraction in Patients with Ph-Negative Myeloproliferative Disorders and Thrombocytosis.

Final Results of the ANAHYDRET-Study: Non-Inferiority of Anagrelide Compared to Hydroxyurea in Newly Diagnosed WHO-Essential Thrombocythemia Patients

JAK2 Mutation and Additional Thrombophilic Markers Predispose to Thrombosis in Myeloproliferative Diseases with Thrombocythemia

Low Molecular Weight Heparin in Sufficient Dose of ≥70 IU/kg as an Effective and Safe Thromboprophylaxis in Patients with Newly Diagnosed Multiple Myeloma during Conventional VAD Induction Therapy.

Non-Inferiority of Anagrelide Compared to Hydroxyurea in Newly Diagnosed Patients with Essential Thrombocythemia: The ANAHYDRET-Study.

Expression of MAGE-A1 and MAGE-A3 in Bone Marrow from Monoclonal Gammapathy to Myeloma Patients.

Phenotypic Analysis of Plasma Cells in Monoclonal Gammopathy and Multiple Myeloma Subjects.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only